2014 – ISSCR Press Releases and Statements

February 4 Decision Reinforces Regulatory Oversight of Stem Cell Treatments

The US District Court of Appeals for the DC Circuit has upheld a lower court ruling that a stem cell treatment described as a procedure falls under the authority of the US Food and Drug Administration (FDA) as a product. This sets a precedent for regulatory oversight of certain stem cell treatments as drugs or biological products in the USA. 

Read the District Court of Appeals Decision
International Society for Stem Cell Research
5215 Old Orchard Road, Suite 270
Skokie, Illinois, USA 60077
+1 224-592-5700